Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Toshi, Imai"'
Autor:
Kensuke Uraguchi, Kenichi Kozakura, Satoshi Oka, Takaya Higaki, Seiichiro Makihara, Toshi Imai, Akira Doi, Tsuyoshi Ohta, Shin Kariya, Kazunori Nishizaki
Publikováno v:
Medical Mycology Case Reports, Vol 30, Iss , Pp 22-25 (2020)
A 70-year-old Japanese man undergoing remission induction therapy for acute monocytic leukemia (AML-M5b) developed fever and headache, and was started on antibiotics and liposomal amphotericin B (L-AMB). There was no improvement, and computed tomogra
Externí odkaz:
https://doaj.org/article/0bd0a1ec0a7f48cbba4ce190304ece83
Autor:
Tomohiro Urata, Kazutaka Sunami, Toshi Imai, Yuichiro Nawa, Yasushi Hiramatsu, Kazuhiko Yamamoto, Soichiro Fujii, Isao Yoshida, Tomofumi Yano, Yusuke Naoi, Kazuhiro Ikeuchi, Hiroki Kobayashi, Katsuma Tani, Shuji Momose, Jun-ichi Tamaru, Merrill Boyle, Aixiang Jiang, Yasuharu Sato, Tadashi Yoshino, Yoshinobu Maeda, David W. Scott, Daisuke Ennishi
Publikováno v:
Blood. 140:6421-6423
Autor:
Keigo, Fujishita, Sando, Yasuhisa, Satoshi, Oka, Yuka, Fujisawa, Takuya, Machida, Toshi, Imai
Publikováno v:
Acta Medica Okayama. 76(1):17-24
R-CHOP therapy is generally performed every 3 weeks. We investigated the effects of extending the interval of R-CHOP therapy for > 1 week on the prognoses of patients with non-indolent non-Hodgkin’s B-cell lymphoma. Among the 338 patients with non-
Autor:
Kenta, Hayashino, Masayuki, Matsuda, Keigo, Fujishita, Jun, Iwata, Miki, Mizobuchi, Munenori, Uemura, Kenji, Yorita, Akiko, Maeshima, Toshi, Imai
Publikováno v:
Journal of Clinical and Experimental Hematopathology. 62:222-225
In the 2016 update of the World Health Organization (WHO) classification of myeloid neoplasms, acute undifferentiated leukemia (AUL) was defined by a lack of lineage-specific markers. AUL has very poor prognosis and no established therapies due to it
Autor:
Tsuyoshi Ohta, Satoshi Oka, Seiichiro Makihara, Kenichi Kozakura, Kensuke Uraguchi, Takaya Higaki, Toshi Imai, Shin Kariya, Akira Doi, Kazunori Nishizaki
Publikováno v:
Medical Mycology Case Reports
Medical Mycology Case Reports, Vol 30, Iss, Pp 22-25 (2020)
Medical Mycology Case Reports, Vol 30, Iss, Pp 22-25 (2020)
A 70-year-old Japanese man undergoing remission induction therapy for acute monocytic leukemia (AML-M5b) developed fever and headache, and was started on antibiotics and liposomal amphotericin B (L-AMB). There was no improvement, and computed tomogra
Publikováno v:
International journal of hematology. 116(4)
Autor:
Toshi Imai, Toshinobu Hayashi, Yasuyo Morita, Koudai Tanaka, Kei Kawada, Mitsuhiko Miyamura, Tsuyoshi Ohta, Hitoshi Fukuda
Publikováno v:
Annals of Hematology. 99:2429-2436
Patients receiving vinca alkaloids for hematological malignancies frequently experience constipation that is unresponsive to laxatives. Research on treatment of vinca alkaloid-induced constipation is limited. This study aimed to determine whether the
Autor:
Yuki Fujiwara, Tomohiro Urata, Daigo Niiya, Tomofumi Yano, Yuichiro Nawa, Isao Yoshida, Toshi Imai, Kazutaka Sunami, Soichiro Fujii, Daisuke Ennishi, Yoshinobu Maeda, Yasushi Hiramatsu
Publikováno v:
International journal of hematology. 115(6)
Progression-free survival in patients with untreated follicular lymphoma (FL) has significantly improved with obinutuzumab plus chemotherapy followed by obinutuzumab maintenance, compared with rituximab plus chemotherapy. However, the survival outcom
Autor:
Yasuhisa Sando, Daisuke Ennishi, Takumi Kondo, Shuntaro Ikegawa, Yuka Fujisawa, Yuichi Sumii, Nobuharu Fujii, Kentaro Mizuhara, Noboru Asada, Yoshinobu Maeda, Keiko Fujii, Ken-ichi Matsuoka, Hiroki Kobayashi, Hisakazu Nishimori, Yusuke Meguri, Toshi Imai, Miki Iwamoto, Takuya Fukumi
Publikováno v:
Leukemia. 35:929-931
Autor:
Wataru, Kitamura, Takuya, Machida, Keigo, Fujishita, Satoshi, Oka, Yuka, Fujisawa, Katsuma, Tani, Toshi, Imai
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 61(4)
We present the case of a 39-year-old man with a primary diagnosis of mixed phenotype acute leukemia, T/myeloid not otherwise specified (T/M-MPAL). After achieving a complete remission (CR), he underwent allogeneic hematopoietic stem cell transplantat